Vitamin D protects against colorectal cancer by boosting the immune system

January 15, 2015

A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system's vigilance against tumor cells.

The research, published today by the journal Gut, represents the first time that a link between vitamin D and the to has been shown in a large human population. The finding adds to a growing body of research showing that vitamin D - known as the "sunshine vitamin" because it is produced by the body in response to sunlight exposure - plays a key role in cancer prevention.

"People with high levels of vitamin D in their bloodstream have a lower overall risk of developing ," said the study's senior author, Shuji Ogino, MD, PhD, of Dana-Farber, Harvard School of Public Health, and Brigham and Women's Hospital. "Laboratory research suggests that vitamin D boosts by activating T cells that recognize and attack cancer cells. In this study, we wanted to determine if these two phenomena are related: Does vitamin D's role in the immune system account for the lower rates of colorectal cancer in people with high circulating levels of the vitamin?"

Ogino and his colleagues theorized that if the two phenomena were connected, then people with high levels of vitamin D would be less likely to develop colorectal tumors that are permeated with large numbers of immune system cells. Colorectal tumors that do develop in these individuals would, by the same logic, be more resistant to the immune response.

To determine if this is indeed the case, the research team drew on data from 170,000 participants in the Nurses' Health Study and Health Professionals Follow-up Study, two long-term health-tracking research projects. Within this population, researchers compared carefully selected groups of 318 colorectal cancer patients and 624 individuals who were free of cancer. All 942 of them had blood samples drawn in the 1990s, before any developed cancer. The investigators tested these samples for 25-hydroxyvitamin D, (abbreviated 25(OH)D), a substance produced in the liver from vitamin D.

They found that patients with high amounts of 25(OH)D indeed had a lower-than-average risk of developing colorectal tumors that were enriched with .

"This is the first study to show evidence of the effect of vitamin D on anti-cancer immune function in actual patients, and vindicates basic laboratory discoveries that vitamin D can interact with the to raise the body's defenses against cancer," Ogino said. "In the future, we may be able to predict how increasing an individual's D intake and immune function can reduce his or her risk of colorectal cancer."

Explore further: Vitamin D may raise survival rates among cancer patients

Related Stories

Vitamin D may raise survival rates among cancer patients

April 29, 2014

Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...

Vitamin D deficiency may compromise immune function

February 25, 2014

Older individuals who are vitamin D deficient also tend to have compromised immune function, according to new research accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Recommended for you

Bringing evidence to health screening debates

February 19, 2017

Whether to screen? How often? At what age? At what cost?—seem to readily breed conflicting opinions and public confusion. What's needed is rigorously produced evidence. That's where Constantine Gatsonis, chair of the Department ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.